Icon
+91 94997 68112
Login Register

Izba - (0.003%; Solution/Drops, Ophthalmic)

Travoprost Novartis
0.003%; Solution/Drops, Ophthalmic
Less Than $1000 mn
Less Than 5
Less Than 5
Less Than 5
 None
None None
Indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
Yes
****: *** ******* ** ************ ** ***** ** *-**, ******* ******* *** ***** ****** ** ****** **** *** *** ******* *** ***** ** ***** ********** *** **** **** ******* *********** ***** ******* ******* ***** ** **** ******* ***** ****** *****'* ***** ******* ***********. ****** ** *** ***** ** **** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****) *** *** ************ *********. ****** *** ****** ** ** ****** **** ********** *** ********* **** ******* ***** *** ***** ** ********* *** *** *****.
Izba Patent 1 Patent 2 Patent 3 Patent 4
****** ******* ******* ******* *******
Company FTF Status / 180 days exclusivity 30-Months stay Current Litigation Status Current Approval Status Likelihood of launch
****** *** \ ** *** *, **** ******* **** ****** ***** **** (***** ******)
  1. *** **, **** : ****** ******** ***** ***** *** **** ** **** ******* '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****), '*** (*** **, ****).
  2. *** *, **** : ***** ***** * **** ******* ****** ** ******** ***** ** ********.
  3. *** **, **** : ********** ********* **** ****** ***** *** ***** ** ********* *** *** *****.

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.